ArticleCell death & disease2013

Salirasib sensitizes hepatocarcinoma cells to TRAIL-induced apoptosis through DR5 and survivin-dependent mechanisms.

N Charette et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.